nature.com about npg news@nature.com naturejobs natureevents help site index
my account Submit Manuscript subscribe register
SEARCH     advanced search
Sunday 23 November 2008
Home
News
Research highlights
Research & reviews
Naturejobs drug discovery
Market analysis
About this site
Resources
Horizon
Nature Reviews Drug Discovery
Nature
Nature Biotechnology
Nature Chemical Biology
Nature Medicine
Nature Structural & Molecular Biology
Nature Methods
British Journal of Pharmacology
The Pharmacogenomics Journal
Bioentrepreneur
Neuropsycho-
pharmacology
  Molecular Psychiatry
  Signaling Gateway
  Pathway Interaction Database
  Functional Glycomics Gateway
  Neuroscience Gateway
  Clinical Pharmacology & Therapeutics
  Nature Reports Stem Cells
  Nature Reports Avian Flu
 
 

Research & reviews

This month's research & review articles

Novel therapeutic strategies for multiple sclerosis – a multifaceted adversary
Understanding of the immunopathogenesis of multiple sclerosis has opened up exciting avenues and novel potential targets to affect the natural course of the disease.
31 October 2008
New regulators of NF-κB in inflammation
Approaches to target NF-κB in inflammatory disease must consider the varied contributions of the NF-[kappa]B transcription-factor family in various signalling pathways.
31 October 2008
Network pharmacology: the next paradigm in drug discovery
Network pharmacology: the next paradigm in drug discovery
31 October 2008
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Valproic acid, a histone deacetylase inhibitor, enables reprogramming of primary human fibroblasts with only two factors, Oct4 and Sox2, without the need for the oncogenes c-Myc or Klf4.
31 October 2008
Home | News | Research highlights | Research & reviews | Naturejobs drug discovery
Market analysis | About this site
© 2008 Nature Publishing Group
Privacy Policy